Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
Status:
Terminated
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate over a 6 month period the effect of octreotide
therapy on food intake, sense of hunger, body weight, body composition, efficiency of burning
calories, biomarkers of weight regulation and growth hormone markers in children and young
Adults with Prader-Willi Syndrome(PWS).
Phase:
N/A
Details
Lead Sponsor:
Duke University
Collaborators:
National Center for Research Resources (NCRR) National Institutes of Health (NIH) Novartis